Goldman Sachs’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $264M | Sell |
1,348,694
-360,231
| -21% | -$70M | 0.03% | 547 |
|
|
2025
Q4 | $297M | Buy |
1,708,925
+645,209
| +61% | +$117M | 0.04% | 478 |
|
|
2025
Q3 | $203M | Buy |
1,063,716
+417,982
| +65% | +$74.2M | 0.02% | 599 |
|
|
2025
Q2 | $116M | Sell |
645,734
-100,303
| -13% | -$17.4M | 0.02% | 808 |
|
|
2025
Q1 | $126M | Sell |
746,037
-167,326
| -18% | -$27.5M | 0.02% | 680 |
|
|
2024
Q4 | $138M | Sell |
913,363
-417,340
| -31% | -$64.9M | 0.02% | 651 |
|
|
2024
Q3 | $207M | Sell |
1,330,703
-409,388
| -24% | -$61.1M | 0.03% | 512 |
|
|
2024
Q2 | $238M | Sell |
1,740,091
-109,831
| -6% | -$15M | 0.04% | 458 |
|
|
2024
Q1 | $246M | Buy |
1,849,922
+1,357,253
| +275% | +$176M | 0.04% | 434 |
|
|
2023
Q4 | $67.9M | Sell |
492,669
-121,550
| -20% | -$16M | 0.01% | 982 |
|
|
2023
Q3 | $74.8M | Sell |
614,219
-57,476
| -9% | -$7.66M | 0.02% | 864 |
|
|
2023
Q2 | $94.4M | Buy |
671,695
+223,172
| +50% | +$30.8M | 0.02% | 738 |
|
|
2023
Q1 | $63.5M | Sell |
448,523
-70,508
| -14% | -$10.1M | 0.01% | 918 |
|
|
2022
Q4 | $81.2M | Sell |
519,031
-95,769
| -16% | -$13.8M | 0.02% | 841 |
|
|
2022
Q3 | $75.4M | Buy |
614,800
+80,455
| +15% | +$10.6M | 0.02% | 837 |
|
|
2022
Q2 | $71.1M | Sell |
534,345
-39,368
| -7% | -$5.36M | 0.02% | 886 |
|
|
2022
Q1 | $78.5M | Sell |
573,713
-78,018
| -12% | -$10.9M | 0.02% | 925 |
|
|
2021
Q4 | $113M | Sell |
651,731
-682,832
| -51% | -$104M | 0.02% | 731 |
|
|
2021
Q3 | $194M | Buy |
1,334,563
+596,838
| +81% | +$87.3M | 0.04% | 432 |
|
|
2021
Q2 | $97.4M | Buy |
737,725
+239,200
| +48% | +$31.3M | 0.02% | 751 |
|
|
2021
Q1 | $64M | Buy |
498,525
+6,312
| +1% | +$778K | 0.02% | 964 |
|
|
2020
Q4 | $58.7M | Sell |
492,213
-92,166
| -16% | -$11.2M | 0.02% | 1002 |
|
|
2020
Q3 | $66.9M | Sell |
584,379
-37,067
| -6% | -$4.38M | 0.02% | 797 |
|
|
2020
Q2 | $70.8M | Sell |
621,446
-167,566
| -21% | -$17.8M | 0.02% | 723 |
|
|
2020
Q1 | $63.4M | Sell |
789,012
-416,321
| -35% | -$43.1M | 0.02% | 720 |
|
|
2019
Q4 | $129M | Buy |
1,205,333
+313,407
| +35% | +$32.7M | 0.03% | 578 |
|
|
2019
Q3 | $95.5M | Buy |
891,926
+37,857
| +4% | +$3.89M | 0.03% | 685 |
|
|
2019
Q2 | $87M | Sell |
854,069
-24,585
| -3% | -$2.36M | 0.03% | 764 |
|
|
2019
Q1 | $79M | Sell |
878,654
-122,842
| -12% | -$10.6M | 0.02% | 811 |
|
|
2018
Q4 | $83.4M | Buy |
1,001,496
+9,029
| +0.9% | +$846K | 0.03% | 720 |
|
|
2018
Q3 | $107M | Buy |
992,467
+47,937
| +5% | +$5.26M | 0.03% | 717 |
|
|
2018
Q2 | $104M | Sell |
944,530
-888,433
| -48% | -$92.6M | 0.03% | 704 |
|
|
2018
Q1 | $184M | Buy |
1,832,963
+89,264
| +5% | +$9.14M | 0.05% | 463 |
|
|
2017
Q4 | $172M | Sell |
1,743,699
-318,408
| -15% | -$30.2M | 0.04% | 522 |
|
|
2017
Q3 | $193M | Buy |
2,062,107
+115,254
| +6% | +$12.2M | 0.05% | 444 |
|
|
2017
Q2 | $216M | Buy |
1,946,853
+178,351
| +10% | +$18.9M | 0.06% | 371 |
|
|
2017
Q1 | $174M | Sell |
1,768,502
-167,538
| -9% | -$16M | 0.05% | 443 |
|
|
2016
Q4 | $178M | Sell |
1,936,040
-1,172
| -0.1% | -$101K | 0.05% | 441 |
|
|
2016
Q3 | $164M | Buy |
1,937,212
+157,915
| +9% | +$13.3M | 0.05% | 437 |
|
|
2016
Q2 | $145M | Sell |
1,779,297
-154,806
| -8% | -$11.8M | 0.05% | 479 |
|
|
2016
Q1 | $138M | Buy |
1,934,103
+269,012
| +16% | +$18M | 0.05% | 501 |
|
|
2015
Q4 | $118M | Buy |
1,665,091
+678,813
| +69% | +$45.6M | 0.04% | 576 |
|
|
2015
Q3 | $60.6M | Sell |
986,278
-83,680
| -8% | -$5.85M | 0.02% | 908 |
|
|
2015
Q2 | $77.6M | Buy |
1,069,958
+60,863
| +6% | +$4.49M | 0.02% | 818 |
|
|
2015
Q1 | $77.5M | Buy |
1,009,095
+423,586
| +72% | +$30.3M | 0.02% | 790 |
|
|
2014
Q4 | $39.3M | Sell |
585,509
-338,243
| -37% | -$21.3M | 0.01% | 1303 |
|
|
2014
Q3 | $56.1M | Buy |
923,752
+131,281
| +17% | +$8.09M | 0.02% | 987 |
|
|
2014
Q2 | $46.5M | Buy |
792,471
+120,713
| +18% | +$7.07M | 0.01% | 1158 |
|
|
2014
Q1 | $38.9M | Sell |
671,758
-564,822
| -46% | -$30.3M | 0.01% | 1240 |
|
|
2013
Q4 | $66.2M | Buy |
1,236,580
+606,156
| +96% | +$36M | 0.02% | 872 |
|
|
2013
Q3 | $39M | Sell |
630,424
-3,141,376
| -83% | -$188M | 0.01% | 1134 |
|
|
2013
Q2 | $229M | Buy |
+3,771,800
| New | +$225M | 0.09% | 225 |
|
Other funds holding DGX
VCM
VPM
EIG
Goldman Sachs's DGX Position: Q1 2026 in Review
Goldman Sachs reduced its Quest Diagnostics (DGX) stake by 21% in Q1 2026, selling an estimated $70M and leaving 1,348,694 shares worth $264M. The position accounts for 0.03% of the portfolio, ranked #547.
Goldman Sachs first reported a position in DGX in Q2 2013 and has held it in 52 quarters since. The position peaked at $297M in Q4 2025. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.
- Goldman Sachs held 1,348,694 shares of Quest Diagnostics worth $264M as of Q1 2026.
- Goldman Sachs sold 360,231 Quest Diagnostics shares in Q1 2026, an estimated $70M.
- Quest Diagnostics made up 0.03% of Goldman Sachs's portfolio in Q1 2026, its #547 holding.
- Goldman Sachs first reported a position in Quest Diagnostics in Q2 2013 and has held it in 52 quarters since.
- Goldman Sachs's Quest Diagnostics position peaked at $297M in Q4 2025.
- 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.